These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 835542)

  • 21. Effect of ursodeoxycholic acid on biliary bile acid and bile lipid composition in gallstone patients.
    Stiehl A; Raedsch R; Rudolph G; Walker S
    Hepatology; 1984; 4(1):107-11. PubMed ID: 6693062
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of chenodeoxycholic acid and phenobarbital on the rate-limiting enzymes of hepatic cholesterol and bile acid synthesis in patients with gallstones.
    Coyne MJ; Bonorris GG; Goldstein LI; Schoenfield LJ
    J Lab Clin Med; 1976 Feb; 87(2):281-91. PubMed ID: 1245792
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biliary lipid metabolism in gallstone disease and during gallstone dissolution treatment.
    Nilsell K
    Acta Chir Scand Suppl; 1985; 528():1-38. PubMed ID: 3866449
    [No Abstract]   [Full Text] [Related]  

  • 24. Portal venous bile acids in cholesterol gallstone disease: effect of treatment with chenodeoxycholic and cholic acids.
    Einarsson K; Ahlberg J; Angelin B; Björkhem I; Ewerth S
    Hepatology; 1985; 5(4):661-5. PubMed ID: 4018738
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biliary lipid synthesis and secretion in gallstone patients before and during treatment with chenodeoxycholic acid.
    Key PH; Bonorris GG; Marks JW; Chung A; Schoenfield LJ
    J Lab Clin Med; 1980 Jun; 95(6):816-26. PubMed ID: 7381293
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Minimum effective dose of chenic acid for gallstone patients: reduction with bedtime administration and low cholesterol diet.
    Maudgal DP; Kupfer RM; Northfield TC
    Gut; 1982 Apr; 23(4):280-4. PubMed ID: 7076005
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pretreatment biliary lipid composition in white patients with radiolucent gallstones in the National Cooperative Gallstone Study.
    Hofmann AF; Grundy SM; Lachin JM; Lan SP; Baum RA; Hanson RF; Hersh T; Hightower NC; Marks JW; Mekhjian H; Shaefer RA; Soloway RD; Thistle JL; Thomas FB; Tyor MP
    Gastroenterology; 1982 Oct; 83(4):738-52. PubMed ID: 7106505
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Comparison of the effects of an equal dose of 15 mg/kg/day of chenodeoxycholic and ursodeoxycholic acid on the composition of biliary lipids and acids in the bile in radiotransparent biliary lithiasis].
    Garrido G; Breto M; Alegre B; Pérez Aguilar F; Berenguer J
    Rev Esp Enferm Apar Dig; 1983 Oct; 64(4):261-9. PubMed ID: 6658120
    [No Abstract]   [Full Text] [Related]  

  • 29. Changes of bile acid and lipid composition in blood and bile in the clinical course after the initiation of cheno- and ursodeoxycholic acid therapy in patients with cholesterol gallstones.
    Iwamura K
    Tokai J Exp Clin Med; 1982 Nov; 7(6):671-83. PubMed ID: 7184199
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of sodium acetyl salicylate on cholesterol saturation of fasting gall bladder bile, with and without chenic acid.
    Kupfer RM; Northfield TC
    Br J Clin Pharmacol; 1983 Jan; 15(1):114-6. PubMed ID: 6849734
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatic morphology and bile acid composition of bile and urine during chenodeoxycholic acid therapy for radiolucent gallstones.
    Pedersen L; Bremmelgaard A
    Scand J Gastroenterol; 1976; 11(4):385-9. PubMed ID: 935799
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The cholesterol saturation of bile and its reduction by chenodeoxycholic acid in massively obese patients.
    Whiting MJ; Hall JC; Iannos J; Roberts HG; Watts JM
    Int J Obes; 1984; 8(6):681-8. PubMed ID: 6533091
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changes in biliary lipid and biliary bile acid composition in patients after administration of ursodeoxycholic acid.
    Makino I; Nakagawa S
    J Lipid Res; 1978 Aug; 19(6):723-8. PubMed ID: 690512
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 7-Methyl bile acids: effects of chenodeoxycholic acid, cholic acid, and their 7 beta-methyl analogues on the formation of cholesterol gallstones in the prairie dog.
    Matoba N; Cohen BI; Mosbach EH; Stenger RJ; Kuroki S; Une M; McSherry CK
    Gastroenterology; 1989 Jan; 96(1):178-85. PubMed ID: 2909419
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative efficacy and side effects of ursodeoxycholic and chenodeoxycholic acids in dissolving gallstones. A double-blind controlled study.
    Fromm H; Roat JW; Gonzalez V; Sarva RP; Farivar S
    Gastroenterology; 1983 Dec; 85(6):1257-64. PubMed ID: 6354826
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bile acids in bile during long-term chenodeoxycholic acid treatment.
    Bremmelgaard A; Pedersen L
    Scand J Gastroenterol; 1976; 11(2):161-5. PubMed ID: 1265436
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biliary lipid output during three meals and an overnight fast. II. Effect of chenodeoxycholic acid treatment in gallstone subjects.
    Northfield TC; LaRusso NF; Hofmann AF; Thistle JL
    Gut; 1975 Jan; 16(1):12-7. PubMed ID: 1140620
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of fixed doses of chenodeoxycholic acid for gallstone dissolution.
    Bateson MC; Ross PE; Murison J; Bouchier IA
    Lancet; 1978 May; 1(8074):1111-4. PubMed ID: 77412
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gallstone dissolution treatment with a combination of chenodeoxycholic and ursodeoxycholic acids. Studies of safety, efficacy and effects on bile lithogenicity, bile acid pool, and serum lipids.
    Roehrkasse R; Fromm H; Malavolti M; Tunuguntla AK; Ceryak S
    Dig Dis Sci; 1986 Oct; 31(10):1032-40. PubMed ID: 3757719
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Alterations of bile acid metabolism during treatment with chenodeoxycholic acid. Studies of the role of the appearance of ursodeoxycholic acid in the dissolution of gallstones (author's transl)].
    Fromm H; Erbler HC; Eschler A; Schmidt FW
    Klin Wochenschr; 1976 Dec; 54(23):1125-31. PubMed ID: 1003870
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.